Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Action Pin has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner, PACKARD, BENJAMIN J. The action is located within 1 distinct art unit. PACKARD, BENJAMIN J is the busiest examiner with 1 pending office action, which accounts for the entire pending workload in the Biotechnology & Pharmaceuticals area.
This profile reflects a very focused and limited prosecution presence. With only a single pending action, the company's current activity in the Biotechnology & Pharmaceuticals sector is concentrated under a single examiner and art unit. Practitioners should note that the assigned examiner is the sole individual responsible for this case. The presence of 1 distinct art unit ensures a highly specific organizational context for this application. This streamlined prosecution environment means that the outcome for the company is entirely dependent on the interaction with this one official.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PACKARD, BENJAMIN J | 1 | 67.0% | +15.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19113076 | USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS | PACKARD, BENJAMIN J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19113076 | USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS | PACKARD, BENJAMIN J | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19113076 | USE OF RESIN ACIDS AS DEFENSE GENE INDUCERS FOR BIOTIC STRESS IN PLANTS | PACKARD, BENJAMIN J | 1612 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 19, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAction Pin has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Benjamin J Packard has the most, with 1 of Action Pin's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.